AstraZeneca (AZN)
(Delayed Data from NSDQ)
$78.38 USD
-0.52 (-0.66%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $78.50 +0.12 (0.15%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Brokerage Reports
AstraZeneca PLC [AZN]
Reports for Purchase
Showing records 21 - 40 ( 263 total )
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for AZN 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 7
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended June 30.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended May 5.
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended April 28.
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department